Digital Breast Tomosynthesis Equipment Market - Growth, Trends, COVID-19 Impact, and Forecasts (2022 - 2027)

The market is segmented By Product Type (2D/3D Combination Mammography Systems, Standalone 3D Mammography Systems), By End User and Geography.

Market Snapshot

digital breast tomosynthesis equipment 1
Study Period: 2018 - 2026
Base Year: 2021
Fastest Growing Market: Asia Pacific
Largest Market: North America
CAGR: 13.5 %

Need a report that reflects how COVID-19 has impacted this market and its growth?

Market Overview

The Digital Breast Tomosynthesis Equipment Market is expected to register a CAGR of 13.5% during the forecast period. Digital breast tomosynthesis is a high-resolution limited-angle tomography technique that creates a 3-dimensional picture of the breast using X-rays. It is a new technology that helps in the early detection of breast cancer.

Digital breast tomosynthesis is especially useful in examining dense breasts and can improve and increase the ability to find breast cancer. It reduces the rate of false-positive readings (a reading that identifies normal tissue as an abnormality) and also reduces the need for a biopsy. It can be performed for any woman, but it is especially beneficial for women who have dense breasts.

According to the American Cancer Society in 2019, approximately 1 in 8 women (13%) will be diagnosed with invasive breast cancer in their lifetime and 1 in 39 women (3%) will die from breast cancer in the United States. Moreover, more than 150,000 breast cancer survivors are living with metastatic disease, three-fourths of whom were originally diagnosed with stage I-III in the United States. Increasing the prevalence of breast cancer worldwide, growing awareness about the use of tomosynthesis and technological advancements for developing new innovative imaging products are the key driving factors in digital breast tomosynthesis equipment market.

Scope of the Report

As per the scope of the report, Digital breast tomosynthesis (DBT) or 3D mammography is an advanced form of mammography, that uses low-dose x-rays to detect cancer early when it is most treatable. Digital breast tomosynthesis equipment market is segmented by product type, end-user and Geography.

By Product Type
2D/3D Combination Mammography Systems
Standalone 3D Mammography Systems
By End User
Diagnostic Centers
Other End-users
North America
United States
United Kingdom
Rest of Europe
South Korea
Rest of Asia-Pacific
Middle-East and Africa
South Africa
Rest of Middle-East and Africa
South America
Rest of South America

Report scope can be customized per your requirements. Click here.

Key Market Trends

2D/3D Combination Mammography Systems Segment is Expected to Hold a Major Market Share in the Digital Breast Tomosynthesis (DBT) Equipment Market

2D/3D Combination Mammography Systems segment holds a significant market share in the digital breast tomosynthesis equipment market and is anticipated to show a similar trend over the forecast period. Combined 2D/3D mammography systems are superior to 2D mammography alone in the diagnosis of breast cancer because as shown by a number of large studies. As per the American Society of Clinical Oncology (ASCO) clinical trial report, a large US study of 4,54,850 patients found that combined 2D/3D Combination screening-detected 5.5 cancers per 1,000 women, compared with 4.3 cancers for 2D screening alone, a 28% higher detection rate with combined 2D/3D mammography systems. According to World Health Organization (WHO), breast cancer is the most frequent type of cancer among women globally, approximately 2.1 million women suffer from breast cancer every year, and with the highest number of cancer-related deaths among women. In the year 2018, it was estimated that approximately 627,000 women died from breast cancer that is nearly 15% of all cancer deaths among women globally. Furthermore, rising awareness about the use of these systems and high detection rates are the key driving factors in the 2D/3D combination mammography systems segment.

Digital Breast Tomosynthesis key trend 2.png

North America is Expected to Hold a Significant Share in the Market and Expected to do Same in the Forecast Period

North America is expected to hold a major market share in the global digital breast tomosynthesis (DBT) equipment market due to the high demand for innovative products, increasing adoption of screening, and the presence of trained healthcare professionals in this region. According to the National Breast Cancer Foundation, in the year 2019, 62% of breast cancer cases were diagnosed at a localized stage. Female breast cancer represents approximately 15.2% of all new cancer cases in the United States. Furthermore, technological advancements in the field of breast imaging, the presence of well-established healthcare infrastructure and increasing healthcare spending are also fueling the growth of the overall regional market to a large extent.

Digital Breast Tomosynthesis Equipment Market 2

Competitive Landscape

The Digital Breast Tomosynthesis Equipment Market is Consolidated competitive and consists of a few major players. Some of the prominent players operating in the digital breast tomosynthesis (DBT) Equipment market are Hologic, Inc, GE Healthcare, Fujifilm Holdings Corporation, Siemens Healthineers, General Medical Merate SpA (IMS GIOTTO SPA), Planmed Oy, Analogic Corporation and Trivitron Healthcare.

Table of Contents


    1. 1.1 Study Assumptions

    2. 1.2 Scope of the Study




    1. 4.1 Market Overview

    2. 4.2 Market Drivers

      1. 4.2.1 Increasing Prevalence of Breast Cancer Worldwide

      2. 4.2.2 Technological Advancements in the Field of Breast Imaging

      3. 4.2.3 Rising Awareness About the Use of Digital Breast Tomosynthesis (DBT)

    3. 4.3 Market Restraints

      1. 4.3.1 High Costs of the Systems

      2. 4.3.2 Side Effects Associated with Radiation Exposure

    4. 4.4 Porter's Five Force Analysis

      1. 4.4.1 Threat of New Entrants

      2. 4.4.2 Bargaining Power of Buyers/Consumers

      3. 4.4.3 Bargaining Power of Suppliers

      4. 4.4.4 Threat of Substitute Products

      5. 4.4.5 Intensity of Competitive Rivalry


    1. 5.1 By Product Type

      1. 5.1.1 2D/3D Combination Mammography Systems

      2. 5.1.2 Standalone 3D Mammography Systems

    2. 5.2 By End User

      1. 5.2.1 Hospitals

      2. 5.2.2 Diagnostic Centers

      3. 5.2.3 Other End-users

    3. 5.3 Geography

      1. 5.3.1 North America

        1. United States

        2. Canada

        3. Mexico

      2. 5.3.2 Europe

        1. Germany

        2. United Kingdom

        3. France

        4. Italy

        5. Spain

        6. Rest of Europe

      3. 5.3.3 Asia-Pacific

        1. China

        2. Japan

        3. India

        4. Australia

        5. South Korea

        6. Rest of Asia-Pacific

      4. 5.3.4 Middle-East and Africa

        1. GCC

        2. South Africa

        3. Rest of Middle-East and Africa

      5. 5.3.5 South America

        1. Brazil

        2. Argentina

        3. Rest of South America


    1. 6.1 Company Profiles

      1. 6.1.1 Hologic, Inc

      2. 6.1.2 GE Healthcare

      3. 6.1.3 Fujifilm Holdings Corporation

      4. 6.1.4 Siemens Healthineers

      5. 6.1.5 General Medical Merate SpA (IMS GIOTTO SPA)

      6. 6.1.6 Planmed Oy

      7. 6.1.7 Analogic Corporation

      8. 6.1.8 Trivitron Healthcare

    2. *List Not Exhaustive

**Competitive Landscape covers- Business Overview, Financials, Products and Strategies, and Recent Developments

You can also purchase parts of this report. Do you want to check out a section wise price list?

Frequently Asked Questions

The undefined market is studied from 2018 - 2026.

The undefined is growing at a CAGR of 13.5% over the next 5 years.

Asia Pacific is growing at the highest CAGR over 2021- 2026.

North America holds highest share in 2020.

Hologic, Inc, GE Healthcare, Fujifilm Holdings Corporation, Siemens Healthineers, Planmed Oy are the major companies operating in undefined.

80% of our clients seek made-to-order reports. How do you want us to tailor yours?

Please enter a valid email id!

Please enter a valid message!